This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

TIDES USA: Oligonucleotide & Peptide Therapeutics

SAVINGS DEADLINE EXPIRES IN:

  • 00
    Days
  • 00
    Hrs
  • 00
    Mins
  • 00
    Secs
May 14-17, 2024 | In-Person + Digital
Boston, MA, USAHynes Convention Center
May 14-17, 2024 | In-Person + Digital
Boston, MA, USA,
Hynes Convention Center

Industry’s Largest & Most Renowned Event to Accelerate Your Oligo and Peptide Therapeutics to Market: Leading Strategies for Expediting R&D and Improving CMC Efficiency.

ACCESS NOVEL SCIENCE ACROSS THE ENTIRE OLIGONUCLEOTIDE, PEPTIDE, AND MRNA SPECTRUM

Cross-fertilize Ideas and Best Practices with Industry Experts Across Multiple Discipline Areas.

The TIDES USA program features concurrent tracks covering the following 6 scientific themes including in-depth development strategies, trends, and technologies across the entire spectrum of oligonucleotides, peptides, mRNA, and genome editing. Your registration provides access to the presentations across all 4 tracks, allowing you to create your own customized agenda.

Oligonucleotide Chemistry, Manufacturing & Controls

Comprehensive CMC, analytical, manufacturing and regulatory strategies for both drug substance and drug product to accelerate oligonucleotide product development.

Oligonucleotide Discovery, Preclinical and Clinical

Design oligonucleotides with better drug-like properties to accelerate your products to the clinic and to market. The latest preclinical and clinical updates to benchmark your research and improve your clinical efforts.

Peptide Chemistry, Manufacturing & Controls

Improve process efficiencies and overcome challenges in process development, CMC and manufacturing. Understand regulatory expectations, new technologies and alternative approaches for emerging complex molecules.

Peptide Discovery, Preclinical and Clinical

Explore new frontiers in peptide synthesis, discovery, design and engineering to improve targeting, delivery and drug-like properties. Case studies on the latest preclinical and clinical successes of peptides and peptide-like scaffolds and structures.

mRNA Therapeutics/Vaccines & Genome Editing

Hear updates on discovery strategies, clinical progress and CMC approaches for mRNA therapeutics and vaccines from industry-leading companies, and learn about state-of-the-art technologies for genome editing applications and hear about progress in genome editing delivery

Drug Delivery Innovations

Explore new technologies and approaches in the delivery of macromolecular therapeutics featuring multiple case studies of the delivery of oligonucleotides, peptides, mRNA therapeutics and genome editing delivery strategies. Learn about cutting-edge delivery advances including targeted delivery approaches for oligonucleotides, device-based delivery strategies and oral delivery of peptides.

Connect with the industry anywhere in the world!

Whether you're increasing your company profile, launching a new product, or focusing on new business development opportunities, collaborate with us to identify custom solutions to help you reach your goals. 

To begin building your custom sponsorship package today, contact:

Companies #, A-F: Jennifer Wickett, JWickett@informaconnectls.com

Companies G-Z: Michael Moriarty, MMoriarty@informaconnectls.com


Jesper Lau, Ph.D.

VP, Protein and Peptide Chemistry

Novo Nordisk, Denmark

The yearly TIDES conferences are among the most important events within peptide and oligonucleotide discovery and development and it has always been among my high priority to be able to join them. I am thus delighted to learn that Informa Connect will deliver TIDES USA Boston 2020 in a virtual format, and I am convinced that a digital meeting will be extremely appreciated in order to continue the important global communication among the scientific communities during these tough times.

Big Waves at TIDES USA 2023

Onsite highlights from TIDES USA 2023 - the biggest TIDES event EVER

TIDES China Research Survey

The TIDES team is exploring the feasibility of running digital & in-person events in China for companies working in oligonucleotides, peptides, mRNA, genome editing (or delivery of any of these modalities). If you are interested in the TIDES market in China and/or have contacts in your network who are, please complete this short survey and we will be sure to keep you updated on our China plans.